Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2012

CYP2C9 gene polymorphisms and warfarin dose requirement: a single-center experience in Turkey

Rahşan YILDIRIM, Mehmet GÜNDOĞDU, Fatih Kurnaz, Abdulkadir YILDIRIM, Hülya AKSOY, Fuat Erdem, İlhami KİKİ, Emin Murat Akbas, Serkan Cerrah

TURKISH JOURNAL OF MEDICAL SCIENCES Cilt 42 · Sayı 6 · ss. 981–986 · 01.12.2012
DOI ile aç

Özet

Aim: In this study, we aimed to evaluate the relationship between genetic structure and daily dose requirement in patients under warfarin therapy presenting at our hospital.

Atıf için künye

YILDIRIM, R., GÜNDOĞDU, M., Kurnaz, F., YILDIRIM, A., AKSOY, H., Erdem, F., KİKİ, İ., Akbas, E. M., & Cerrah, S. (2012). CYP2C9 gene polymorphisms and warfarin dose requirement: a single-center experience in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES, 42(6), 981–986. https://doi.org/10.3906/sag-1112-46

BibTeX
@article{yildirim2012-228506,
  author = {YILDIRIM, Rahşan and GÜNDOĞDU, Mehmet and Kurnaz, Fatih and YILDIRIM, Abdulkadir and AKSOY, Hülya and Erdem, Fuat and KİKİ, İlhami and Akbas, Emin Murat and Cerrah, Serkan},
  title = {CYP2C9 gene polymorphisms and warfarin dose requirement: a single-center experience in Turkey},
  journal = {TURKISH JOURNAL OF MEDICAL SCIENCES},
  year = {2012},
  volume = {42},
  number = {6},
  pages = {981--986},
  issn = {1300-0144},
  doi = {10.3906/sag-1112-46},
  url = {https://akademik.atauni.edu.tr/yayinlar/228506-cyp2c9-gene-polymorphisms-and-warfarin-dose-requirement-a-single-center}
}